Expression and sequence analyses of p33ING1 gene in myeloid leukemia

Keisuke Ito, K. Kinjo, T. Nakazato, Y. Ikeda, M. Kizaki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

p33ING1 is a novel candidate tumor suppressor gene which is involved in the regulation of apoptosis. p33ING1 interacts with p53 signaling pathway and regulates cellular growth. It has reported that the expression of p33ING1 mRNA was decreased in lymphoid malignancies. We thus investigated the potential involvement of p33ING1 abnormalities in myeloid leukemias. However, the levels of p33ING1 transcript were almost equal in 3 AML cell lines and 10 fresh AML samples. In addition, neither point mutations nor deletions in p33ING1 gene were found in myeloid leukemias. These results suggest that p33ING1 may not be a major candidate tumor suppressor gene in myeloid leukemias.

Original languageEnglish (US)
Pages (from-to)141-143
Number of pages3
JournalAmerican Journal of Hematology
Volume69
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Myeloid Leukemia
Sequence Analysis
Tumor Suppressor Genes
Genes
Point Mutation
Apoptosis
Cell Line
Messenger RNA
Growth
Neoplasms

Keywords

  • Direct sequence
  • Myeloid leukemia
  • p33
  • p53
  • RT-PCR

ASJC Scopus subject areas

  • Hematology

Cite this

Expression and sequence analyses of p33ING1 gene in myeloid leukemia. / Ito, Keisuke; Kinjo, K.; Nakazato, T.; Ikeda, Y.; Kizaki, M.

In: American Journal of Hematology, Vol. 69, No. 2, 2002, p. 141-143.

Research output: Contribution to journalArticle

Ito, Keisuke ; Kinjo, K. ; Nakazato, T. ; Ikeda, Y. ; Kizaki, M. / Expression and sequence analyses of p33ING1 gene in myeloid leukemia. In: American Journal of Hematology. 2002 ; Vol. 69, No. 2. pp. 141-143.
@article{be9ddb0889b24ef6a0a5c4de23990fe6,
title = "Expression and sequence analyses of p33ING1 gene in myeloid leukemia",
abstract = "p33ING1 is a novel candidate tumor suppressor gene which is involved in the regulation of apoptosis. p33ING1 interacts with p53 signaling pathway and regulates cellular growth. It has reported that the expression of p33ING1 mRNA was decreased in lymphoid malignancies. We thus investigated the potential involvement of p33ING1 abnormalities in myeloid leukemias. However, the levels of p33ING1 transcript were almost equal in 3 AML cell lines and 10 fresh AML samples. In addition, neither point mutations nor deletions in p33ING1 gene were found in myeloid leukemias. These results suggest that p33ING1 may not be a major candidate tumor suppressor gene in myeloid leukemias.",
keywords = "Direct sequence, Myeloid leukemia, p33, p53, RT-PCR",
author = "Keisuke Ito and K. Kinjo and T. Nakazato and Y. Ikeda and M. Kizaki",
year = "2002",
doi = "10.1002/ajh.10031",
language = "English (US)",
volume = "69",
pages = "141--143",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Expression and sequence analyses of p33ING1 gene in myeloid leukemia

AU - Ito, Keisuke

AU - Kinjo, K.

AU - Nakazato, T.

AU - Ikeda, Y.

AU - Kizaki, M.

PY - 2002

Y1 - 2002

N2 - p33ING1 is a novel candidate tumor suppressor gene which is involved in the regulation of apoptosis. p33ING1 interacts with p53 signaling pathway and regulates cellular growth. It has reported that the expression of p33ING1 mRNA was decreased in lymphoid malignancies. We thus investigated the potential involvement of p33ING1 abnormalities in myeloid leukemias. However, the levels of p33ING1 transcript were almost equal in 3 AML cell lines and 10 fresh AML samples. In addition, neither point mutations nor deletions in p33ING1 gene were found in myeloid leukemias. These results suggest that p33ING1 may not be a major candidate tumor suppressor gene in myeloid leukemias.

AB - p33ING1 is a novel candidate tumor suppressor gene which is involved in the regulation of apoptosis. p33ING1 interacts with p53 signaling pathway and regulates cellular growth. It has reported that the expression of p33ING1 mRNA was decreased in lymphoid malignancies. We thus investigated the potential involvement of p33ING1 abnormalities in myeloid leukemias. However, the levels of p33ING1 transcript were almost equal in 3 AML cell lines and 10 fresh AML samples. In addition, neither point mutations nor deletions in p33ING1 gene were found in myeloid leukemias. These results suggest that p33ING1 may not be a major candidate tumor suppressor gene in myeloid leukemias.

KW - Direct sequence

KW - Myeloid leukemia

KW - p33

KW - p53

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=0036154051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036154051&partnerID=8YFLogxK

U2 - 10.1002/ajh.10031

DO - 10.1002/ajh.10031

M3 - Article

VL - 69

SP - 141

EP - 143

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -